We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEDP icon
1001
Medpace
MEDP
$16.5B
$17K ﹤0.01%
203
-24
-11% -$1.86K
PTCT icon
1002
PTC Therapeutics
PTCT
$6.29B
$17K ﹤0.01%
348
-17
-5% -$722
QURE icon
1003
uniQure
QURE
$2.63B
$17K ﹤0.01%
246
+7
+3% +$384
WNS
1004
DELISTED
WNS Holdings
WNS
$17K ﹤0.01%
250
GWPH
1005
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$17K ﹤0.01%
166
-22
-12% -$2.47K
BOLD
1006
DELISTED
Audentes Therapeutics, Inc
BOLD
$17K ﹤0.01%
290
CLPR
1007
Clipper Realty
CLPR
$46.4M
$16K ﹤0.01%
1,500
LOGI icon
1008
Logitech
LOGI
$15.5B
$16K ﹤0.01%
360
XLRN
1009
DELISTED
Acceleron Pharma
XLRN
$16K ﹤0.01%
300
-29
-9% -$1.32K
HALO icon
1010
Halozyme
HALO
$9.66B
$15K ﹤0.01%
827
-95
-10% -$1.65K
KOD icon
1011
Kodiak Sciences
KOD
$2.62B
$15K ﹤0.01%
+209
New +$7.6K
FOLD
1012
DELISTED
Amicus Therapeutics
FOLD
$14K ﹤0.01%
1,438
-184
-11% -$1.68K
RARE icon
1013
Ultragenyx Pharmaceutical
RARE
$2.65B
$14K ﹤0.01%
326
-32
-9% -$1.32K
EPZM
1014
DELISTED
Epizyme, Inc
EPZM
$14K ﹤0.01%
571
ARQL
1015
DELISTED
Arqule Inc
ARQL
$14K ﹤0.01%
712
CCXI
1016
DELISTED
ChemoCentryx, Inc.
CCXI
$13K ﹤0.01%
329
-36
-10% -$632
TPTX
1017
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$13K ﹤0.01%
+202
New +$9.61K
ARNA
1018
DELISTED
Arena Pharmaceuticals Inc
ARNA
$13K ﹤0.01%
283
-32
-10% -$1.51K
ZGNX
1019
DELISTED
Zogenix, Inc.
ZGNX
$13K ﹤0.01%
250
-18
-7% -$824
INSM icon
1020
Insmed
INSM
$22.7B
$12K ﹤0.01%
504
-45
-8% -$915
IRWD icon
1021
Ironwood Pharmaceuticals
IRWD
$644M
$12K ﹤0.01%
885
-98
-10% -$1.08K
KB icon
1022
KB Financial Group
KB
$41.5B
$12K ﹤0.01%
+300
New +$11.5K
OMAB icon
1023
Grupo Aeroportuario Centro Norte
OMAB
$5.06B
$12K ﹤0.01%
200
EIDX
1024
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$12K ﹤0.01%
212
-22
-9% -$1.09K
AIMT
1025
DELISTED
Aimmune Therapeutics
AIMT
$12K ﹤0.01%
357
-38
-10% -$1.06K

Similar funds

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.